Press Releases

Date	Title	PDF Version
Jan 30, 2012	Alexion Pharmaceuticals to Report Fourth Quarter and Full Year 2011 Results on Thursday, February 9, 2012
Jan 03, 2012	Alexion to Present at the 30th Annual JP Morgan Healthcare Conference
Dec 28, 2011	Alexion to Acquire Enobia Pharma Corp. and First Potential Treatment for Patients with Hypophosphatasia (HPP)
Dec 12, 2011	New Data Confirm Hemolysis as Predictor of Thromboembolism and Early Death in Patients with PNH and Demonstrate Need To Test High-Risk Patients for PNH
Nov 29, 2011	Soliris® (eculizumab) Granted Marketing Authorization in Europe for Treatment of Patients with Atypical Hemolytic Uremic Syndrome (aHUS)
Nov 23, 2011	Alexion to Present at the 23rd Annual Piper Jaffray Health Care Conference
Nov 10, 2011	Longer-Term Data on Soliris Showed Significant and Sustained Benefits for Patients with aHUS
Nov 07, 2011	Researchers to Present Additional Data on Soliris® (eculizumab) as a Treatment for Patients with PNH and aHUS at ASH Annual Meeting
Oct 20, 2011	Alexion Reports Third Quarter 2011 Results
Oct 06, 2011	Alexion Pharmaceuticals to Report Third Quarter 2011 Results on Thursday, October 20, 2011

Search